• Mashup Score: 0

    The EORTC is proud to announce the full validation of the EORTC Computerised Adaptive Test (CAT) Core.

    Tweet Tweets with this article
    • 📢Proud to announce full validation of EORTC Computerised Adaptive Test (CAT) Core, an innovative, dynamic patient-reported outcome measure (#PROM) to assess #QualityofLife in oncology. Watch our interview with project leaders from @EORTC_QLG. 👇 More: https://t.co/chLvpBqVot https://t.co/96fA0PMUZK

  • Mashup Score: 1

    EORTC is excited to share the publication of the first consensus paper by the SISAQOL-IMI Consortium, outlining the agreed priority PRO objectives

    Tweet Tweets with this article
    • 📚Excited to share the #publication of the 1st consensus paper by @sisaqol Consortium proving an overview of the stakeholders’ views on the need for SISAQOL-IMI and the agreed priority set of patient-reported outcome objectives. 👉 https://t.co/wkulB9UxgR #QualityofLife #cancer https://t.co/EFry5CL0CZ

  • Mashup Score: 0

    Previous version Annual Report 2021 Download .pdf Annual Report 2020 Download .pdf Previous version Annual Report 2021 Download .pdf Annual Report 2020 Download .pdf

    Tweet Tweets with this article
    • 🎉 Excited to announce that the EORTC 2022 #AnnualReport is out! Learn more about EORTC and its most recent activities here: https://t.co/lA1dwKtQY5 #CancerResearch #ClinicalTrials #Oncology https://t.co/qzGyO4B6LI

  • Mashup Score: 1

    Brussels, April 24, 2023 – The European Commission has approved the funding of three new research projects (clinical trials) coordinated by EORTC…

    Tweet Tweets with this article
    • Tomorrow is #ClinicalTrialsDay! Watch the video message from EORTC CEO Dr. Denis Lacombe to learn more about EORTC’s role in #Cancer #ClinicalTrials and the importance of #PragmaticTrials. More: https://t.co/6PrsUzoGQd #CancerResearch #Oncology https://t.co/bylhRDmIbW

  • Mashup Score: 5
    EORTC - 2 year(s) ago

    Skip to content Back to Clinical Trials Database Personalized Risk-Adapted Therapy in Post-Pubertal Patients with Newly-Diagnosed Medulloblastoma…

    Tweet Tweets with this article
    • 🎉EORTC-1634-BTG #PersoMed-I academic phase II #ClinicalTrial, the first worldwide randomised trial in post-pubertal and adults newly diagnosed with #medulloblastoma, has enrolled its first two patients. 👉 https://t.co/2WFkLfgj72 #CancerResearch #ClinicalTrials #BrainCancer https://t.co/dB9ZgDy04q

  • Mashup Score: 0
    Events Manager - EORTC - 2 year(s) ago

    Skip to content The Communications and Events team is looking for an Events Manager responsible for planning and delivering all EORTC internal and external events, held both virtually and in person across Europe. You will be leading a team of four staff members dedicated to ensuring the successful running…

    Tweet Tweets with this article
    • 📢 We're hiring an #EventsManager to lead a dedicated team in planning and delivering impactful #events across Europe. Join our HQ in #Brussels: https://t.co/1AMhPklQUW #JoinOurTeam #WorkWithUs #ClinicalTrials #CancerResearch https://t.co/beIwILNsA6